Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Go back to Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update| (NASDAQ: KNSA) | Delayed: 57.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.13 | 52 Week High | $ | |||
| Open | $57.13 | 52 Week Low | $ | |||
| Day High | $57.13 | P/E | N/A | |||
| Day Low | $57.13 | EPS | $ | |||
| Volume | 4 | |||||

